Skip to main content

Month: April 2022

Perella Weinberg Partners to Announce First Quarter 2022 Financial Results and to Host Conference Call on May 5, 2022

NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) — Perella Weinberg Partners (“PWP”) (NASDAQ:PWP), a leading global independent advisory firm, today announced that it plans to release its financial results for the first quarter 2022 on Thursday, May 5, 2022, before the market opens. Conference Call and Webcast Management will host a conference call and webcast to review PWP’s results on the same day at 9:00AM ET. A webcast of the conference call will be available to the public on a listen-only basis and can be accessed through the Investors section of PWP’s website at https://investors.pwpartners.com. The conference call can also be accessed by the following dial-in information:Domestic: (844) 826-3033 International: (412) 317-5185 Conference ID: 10165467Replay A replay of the call will also be available two hours after the...

Continue reading

Clever Leaves Strengthens Its Presence in the U.S. Through Partnership With Biom Therapeutics

Under the two-year supply agreement Clever Leaves will deliver CBD Isolate to Biom Therapeutics to manufacture a finished product for clinical trials in the United States BOCA RATON, Fla. and SARASOTA, Fla., April 20, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids today announced a two-year supply agreement with American, clinical-stage biopharmaceutical company, Biom Therapeutics (“Biom”) to provide high quality CBD isolate. Clever Leaves has already provided Biom Therapeutics with the first shipment of EU GMP compliant CBD isolate to be manufactured by Biom into formulations for use in studies and clinical trials for rare neurological and developmental diseases. “We are grateful...

Continue reading

Cannabix Technologies Creates Contactless Alcohol Breath Detection Technology for Vehicles – Files Provisional Patent

Cannabix has developed a contactless alcohol breathalyzer for vehicles. New Standards Coming for New Vehicles in the USA and Europe VANCOUVER, British Columbia, April 20, 2022 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that the Company has developed a cutting-edge Contactless Alcohol Breathalyzer for vehicle cabins. The prototype Contactless Alcohol Breathalyzer (“CAB”) was developed by Cannabix after being approached by a Tier 1 global automobile parts manufacturing company seeking to source new technology that could be used in a contactless (no straw, no mouthpiece) method. The Company has entered into a non-disclosure agreement with the Tier 1 global automobile parts manufacturer....

Continue reading

Coop Pank held an investor webinar to introduce unaudited results of Q1 2022

Today, on 20 April 2022 at 10 am (EET), Coop Pank held an investor webinar, where the Chairman of the Board Margus Rink and Chief Financial Officer Paavo Truu introduced the bank’s Q1 2022 unaudited financial results. Webinar was held in Estonian language. Coop Pank would like to thank all participants. Webinar recording is available here: https://youtu.be/Xu_6_–u6WM Coop Pank’s report for unaudited results of Q1 2022 and the presentation is available here:https://view.news.eu.nasdaq.com/view?id=b02c49d25db74ee2618acdc35aed5e572&lang=en Coop Pank, based on Estonian capital, is one of the five universal banks operating in Estonia. The number of clients using Coop Pank for their daily banking has reached 122,400. Coop Pank aims to put the synergy generated by the interaction of retail business and banking to good use and to bring...

Continue reading

Farmers & Merchants Bancorp, Inc. Reports Record 2022 First Quarter Financial Results

ARCHBOLD, Ohio, April 20, 2022 (GLOBE NEWSWIRE) —  Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today reported financial results for the 2022 first quarter ended March 31, 2022. 2022 First Quarter Financial Highlights Include (on a year-over-year basis unless noted):Net income increased 65.0% to a quarterly record of $8.1 million, from $4.9 million Earnings increased 40.9% to $0.62 per basic and diluted share, from $0.44 per basic and diluted share Average shares outstanding increased 16.7% as a result of the Perpetual Federal Savings Bank Acquisition Total loans increased 46.3% to a record $1.962 billion, and included $463,000 of PPP loans Organic loan growth of 22.0%, excluding PPP loans and loan balances at time of acquisitions Total loans increased 5.6% from $1.857 billion at December 31, 2021 Total assets increased...

Continue reading

BlueLinx to Host Investor Day in New York on June 2, 2022

MARIETTA, Ga., April 20, 2022 (GLOBE NEWSWIRE) — BlueLinx Holdings Inc. (NYSE: BXC), a leading U.S. wholesale distributor of building products, will host an in-person investor day event at the New York Stock Exchange on Thursday June 2, 2022, beginning at 10:00 AM ET. Members of the executive leadership team, including Dwight Gibson, President and Chief Executive Officer, and Kelly Janzen, Senior Vice President and Chief Financial Officer, will present a detailed overview of BlueLinx’s strategic priorities and plans for transformational growth followed by a live question-and-answer session. A live webcast of the event and a link to accompanying materials will be available the day of the event in the Investor Relations section of the BlueLinx website at http://bluelinxco.com/webcast-presentations, and a replay of the webcast will...

Continue reading

SANUWAVE Health Announces Patent Activity from March 2021 to March 2022

SANUWAVE announces patents issued over the past year SUWANEE, GA, April 20, 2022 (GLOBE NEWSWIRE) — via NewMediaWire  — SANUWAVE Health, Inc. (SNWV) focuses on the development and commercialization of innovative advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications of shockwave and ultrasound systems in the non-medical field, announced today the patent activity for the past year. For the shockwave technology, the following new patents were issued:US 11,028,670 titled “Shock Wave Device with Far-Field Focused Reflectors” This US patent covers a battery of shock waves applicators positioned on an elliptical or spherical shape support beam to create focused shockwaves that merge and combine to provide pseudo-planar waves over a...

Continue reading

Processa Pharmaceuticals Doses First Patient in Amended Phase 1B Protocol for PCS6422 Combined with Capecitabine (Next Generation Capecitabine)

Processa focuses on identifying the PCS6422 regimens to increase capecitabine potency while identifying the MTD of Next Generation Capecitabine The amended protocol will provide a more precise timeline of DPD inhibition and de novo formation while also supplying preliminary data on the use of an individualized-personalized medicine approach for Next Generation Capecitabine HANOVER, MD, April 20, 2022 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical need conditions, announces today that the first patient with advanced, refractory gastrointestinal cancer has been dosed in its amended maximum tolerated dose (MTD) Phase 1B trial for Next Generation...

Continue reading

Alto Ingredients, Inc. Promotes Stacy Swanson to VP of Quality and Sustainability

Stacy Swanson Stacy Swanson, VP of Quality and Sustainability– Alto Board forms environmental, social and governance subcommittee – SACRAMENTO, Calif., April 20, 2022 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols and essential ingredients, promoted Stacy Swanson to the newly created position of Vice President of Quality and Sustainability effective April 15, 2022. Swanson now reports directly to CEO Mike Kandris. Kandris said, “Specialty alcohol customers seek certifications that assure reliability and surety of supply. Stacy has been instrumental in creating valuable market differentiators for Alto by leading the rigorous certifications process. Having secured ISO 9001, ICH Q7 and EXCiPACT Good Manufacturing Practices certifications as well as...

Continue reading

Your meetings aren’t working: New Verizon study says focus on meeting less to accomplish more

Breaking the bad meetings habit: how Verizon Business is laser-focused on meeting less to accomplish more NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) — Companies rethinking their operations, their working models, and almost every aspect of their business due to the pandemic is not something new. What is noteworthy is seeing how businesses are leveraging lessons learned to innovate and improve their operations to meet customer and employee demands. In a new white paper published this week with Boston Consulting Group, Verizon Business CEO, Tami Erwin, and Verizon Business Chief Revenue Officer, Sampath Sowmyanarayan, break down how something as simple as altering the way meetings are conducted can greatly impact productivity, while providing insight, tips, and best practices from an extensive in-house experiment. “Every leader today...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.